Abstract
Osteogenesis imperfecta describes a group of genetic disorders that result from a defect in collagen type I and range in severity from a subtle increase in fracture frequency to death in the perinatal period. Osteogenesis imperfecta is mostly caused by mutations in the COL1A1 (17q21.33) and COL1A2 (7q21.3) genes. There have only been a few case reports of implant-prosthetic treatment for patients with osteogenesis imperfecta. These reports indicated that implants and augmentation procedures can be implemented in such patients. However, for patients receiving additional antire-sorptive therapy, cautious approaches should be chosen and the risk of drug-associated osteonecrosis should be considered. The aim of this article is to report on the implant-prosthetic treatment of a patient with type I osteogenesis imperfecta.
Author supplied keywords
Cite
CITATION STYLE
Hanisch, M., Maus, M., & Kleinheinz, J. (2021). Implant-prosthetic restoration of a patient with osteogenesis imperfecta: A case report. International Journal of Environmental Research and Public Health, 18(8). https://doi.org/10.3390/ijerph18084169
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.